HKSE - Delayed Quote HKD
WuXi Biologics (Cayman) Inc. (2269.HK)
21.900
-1.350
(-5.81%)
As of 11:18:46 AM GMT+8. Market Open.
Major Holders
Breakdown | |
---|---|
14.84% | % of Shares Held by All Insider |
35.13% | % of Shares Held by Institutions |
41.26% | % of Float Held by Institutions |
321 | Number of Institutions Holding Shares |
Top Institutional Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
Boston Common Asset Management, LLC | 869k | Mar 31, 2024 | 0.02% | 19,031,099 |
Top Mutual Fund Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
VANGUARD WORLD FUND-Vanguard International Growth Fund | 66.04M | Feb 28, 2025 | 1.60% | 1,446,341,674 |
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund | 48.98M | Jan 31, 2025 | 1.19% | 1,072,560,671 |
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Emerging Markets Stock Index Fd | 44.51M | Jan 31, 2025 | 1.08% | 974,759,478 |
iShares, Inc.-iShares Core MSCI Emerging Markets ETF | 31.3M | Mar 31, 2025 | 0.76% | 685,426,188 |
AIM Investment Fd.s -Invesco Developing Markets Fd. | 29.78M | Jan 31, 2025 | 0.72% | 652,214,838 |
DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. PORT. | 9.82M | Jan 31, 2025 | 0.24% | 215,145,596 |
J.P. Morgan Exch-Trd Fd. TRT-JPMorgan BetaBuilders Developed Asia Paci | 9.32M | Jan 31, 2025 | 0.23% | 204,184,646 |
iShares Trust-iShares MSCI China ETF | 8.96M | Mar 31, 2025 | 0.22% | 196,202,096 |
Dimensional Emerging Markets Value Fund | 8.24M | Jan 31, 2025 | 0.20% | 180,565,496 |
iShares, Inc.-iShares MSCI Emerging Markets ETF | 7.35M | Feb 28, 2025 | 0.18% | 161,041,647 |
Related Tickers
1177.HK SINO BIOPHARM
3.870
-2.03%
1801.HK INNOVENT BIO
51.650
-4.88%
1548.HK GENSCRIPT BIO
10.700
-3.60%
6160.HK BeiGene, Ltd.
142.100
-7.25%
1530.HK 3SBIO
11.600
-6.30%
9926.HK Akeso, Inc.
83.800
-3.34%
2126.HK JW (Cayman) Therapeutics Co. Ltd
1.500
-3.23%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
315.600
-6.52%
1873.HK VIVA BIOTECH
1.430
-4.03%
2157.HK Lepu Biopharma Co., Ltd.
4.590
-5.94%